IP Library Granted Patent US 9,175,249
Granted Patent B2
US 9,175,249 · App. 12/831,890 · Granted Nov 3, 2015

Ethyleneoxide butyleneoxide block copolymer compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,175,249
App. No.
12/831,890
Granted
Nov 3, 2015
Kind
B2
Abstract

The present invention relates to compositions comprising ethyleneoxide butyleneoxide and a galactomannan such as guar. The compositions are particularly well suited for ophthalmic applications such as contact lens disinfection and rewetting. Methods for the treatment of dry eye using the compositions of the present invention are also contemplated.

Claims (11)

1. A sterile, aqueous ophthalmic composition comprising an ethyleneoxide butyleneoxide (EO-BO) block copolymer of the formula (EO) m (BO) n and a galactomannan, and wherein m has an average value of 45 and n has an average value of 9 to 18.

2. A composition according to claim 1 wherein m has an average value of 45 and n has an average value of 9 to 11.

3. A composition according to claim 1 wherein said galactomannan is guar.

4. A composition according to claim 3 wherein said guar or guar derivative is selected from the group consisting of:

native guar, hydroxypropyl guar, and hydroxypropyl guar galactomannan.

5. A composition according to claim 1 wherein said EO-BO block copolymer is present at a concentration of 0.001 to 1.0% w/v.

6. A composition according to claim 1 wherein said EO-BO block copolymer is present at a concentration of 0.01 to 0.1% w/v.

7. A composition according to claim 1 wherein said galactomannan is present at a concentration of 0.01 to 2.0% w/v.

8. A composition according to claim 1 wherein said galactomannan is present at a concentration of 0.05 to 0.25% w/v.

9. A method of delivering a pharmaceutical agent to the eye which comprises topically administering to the eye a composition comprising one or more pharmaceutically active agent(s), an ethyleneoxide butyleneoxide block copolymer of the formula (EO) m (BO) n and a galactomannan, and wherein m has an average value of 45 and n has an average value of 9 to 18.

10. A composition according to claim 9 , wherein the pharmaceutically active agent(s) is/are selected from the group consisting of: anti-glaucoma agents, anti-angiogenesis agents; anti-infective agents; anti-inflammatory agents; growth factors; immunosuppressant agents; and anti-allergic agents.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 14, 2019
From: ALCON RESEARCH, LLC
To: ALCON INC.
Reel/Frame 051293/0444 →
MERGER Recorded Dec 11, 2019
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 051257/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2010
From: DAVIS, JAMES W.; KETELSON, HOWARD ALLEN; MEADOWS, DAVID L.
To: ALCON RESEARCH, LTD.
Reel/Frame 024647/0318 →